The Valley Desk

ArticleJAMA network openPublished

Early Addition of Selexipag to Double Therapy for Pulmonary Arterial Hypertension

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
JAMA network open
Published
Subject terms
Humans; Acetamides; Pyrazines; Antihypertensive Agents; Treatment Outcome; Drug Therapy, Combination; Adult; Aged; Middle Aged; Female; Male; Phosphodiesterase 5 Inhibitors
PubMed ID
39312239
PubMed Central ID
PMC11420696
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal